Product NDC: | 0591-3572 |
Proprietary Name: | Fentanyl buccal |
Non Proprietary Name: | Fentanyl buccal |
Active Ingredient(s): | 200 ug/1 & nbsp; Fentanyl buccal |
Administration Route(s): | BUCCAL; ORAL; TRANSMUCOSAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0591-3572 |
Labeler Name: | Watson Laboratories, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA079075 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110107 |
Package NDC: | 0591-3572-96 |
Package Description: | 7 BLISTER PACK in 1 CARTON (0591-3572-96) > 4 TABLET in 1 BLISTER PACK (0591-3572-04) |
NDC Code | 0591-3572-96 |
Proprietary Name | Fentanyl buccal |
Package Description | 7 BLISTER PACK in 1 CARTON (0591-3572-96) > 4 TABLET in 1 BLISTER PACK (0591-3572-04) |
Product NDC | 0591-3572 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Fentanyl buccal |
Dosage Form Name | TABLET |
Route Name | BUCCAL; ORAL; TRANSMUCOSAL |
Start Marketing Date | 20110107 |
Marketing Category Name | ANDA |
Labeler Name | Watson Laboratories, Inc. |
Substance Name | FENTANYL CITRATE |
Strength Number | 200 |
Strength Unit | ug/1 |
Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |